MARKET

APHA

Aphria Inc
APHA
NASDAQ
Delisted
P/E
P/S
P/B
MARKET CAP
-63.5800
10.07
4.086
4,871,546,881.98
Former Tilray CEO Joins Psychedelics Company
More big names in cannabis are switching to psychedelics.
Benzinga · 10/07 20:17
Tilray Bolsters Distribution Partnership With ROSE LifeScience In Quebec
Tilray Inc.'s (NASDAQ: TLRY) (TSX: TLRY) is expanding its distribution partnership with Quebec-based ROSE LifeScience Inc through its subsidiary Tilray Canada Ltd. Under the deal, ROSE became an official partner to the recently created new entity.
Benzinga · 09/17 15:12
Tilray's SweetWater Brewing Co. Announces Expansion Across Michigan, Beer Lovers Delighted
SweetWater Brewing Company, LLC, has ventured into the state of Michigan just weeks following the launch of a new, full-service brewery, production facility, taproom and restaurant in Col
Benzinga · 08/04 13:13
TLRY Stock: The News That Has Cannabis Giant Tilray Moving Today
Investor Place · 07/28 12:40
Curaleaf, Ayr Wellness, Gage Cannabis And Three Others Added To Green Market Report Cannabis Company Index After 'Rough Second Quarter' For Weed Stocks
The Green Market Report Cannabis Company Index has selected the six companies it plans to add for the third quarter while removing six others after the second quarter, which turned out to be "rough for cannabis stocks."
Benzinga · 07/19 18:28
More Cannabis-Inspired Beer: Tilray Continues To Leverage SweetWater Brewing Co, Gaining More Consumers In US
Atlanta-based craft brewery SweetWater Brewing Company, LLC has launched a new brew under its flagship 420 brand.
Benzinga · 07/19 15:54
Tilray CEO Sees Schumer's Pot Bill as Growth Boon
Bloomberg · 07/15 18:32
A Complete List Of NYSE And NASDAQ-Listed Cannabis Companies (Updated)
As the cannabis industry keeps pushing forward, more companies are moving to list their stock on a major U.S. exchange like the NYSE or NASDAQ. The club, however, remains relatively small.
Benzinga · 07/02 18:22
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of APHA. Analyze the recent business situations of Aphria Inc through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 10 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

10.00%Strong Buy
30.00%Buy
60.00%Hold
0.00%Under-perform
0.00%Sell
Analyst Price Target
The average APHA stock price target is 14.53 with a high estimate of 23.51 and a low estimate of 5.80.
High23.51
Average14.53
Low5.80
Current 15.38
EPS
Actual
Estimate
-0.72-0.54-0.36-0.18
Q4 2020
Q1 2021
Q2 2021
Q3 2021
Q4 2021
Institutional Holdings
Institutions: 262
Institutional Holdings: 49.81M
% Owned: 15.72%
Shares Outstanding: 316.75M
TypeInstitutionsShares
Increased
62
12.58M
New
56
10.75M
Decreased
27
3.42M
Sold Out
24
1.27M
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Pharmaceuticals
+0.40%
Pharmaceuticals & Medical Research
-0.64%
Key Executives
Vice President/Director of Marketing
MEGAN Mccrae
Vice President/Director of Sales
Bernie Yeung
Other
.. ..
Vice President
Maureen Berry
Independent Director
Shlomo Bibas
Independent Director
Tom Looney
No Data

Webull offers kinds of Aphria Inc stock information, including NASDAQ:APHA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, APHA stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading APHA stock methods without spending real money on the virtual paper trading platform.